关于公司
Axcentua Pharmaceuticals AB, a pharmaceutical company, generates investigational new drugs for diseases with unmet medical need in Sweden. It offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as pancreatic and non-small cell lung cancers.
SE
未知
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论